China General Manager
As the China General Manager, Jie (Jack) Li leads operations that align with Caidya’s global strategy to drive sustainable growth in the Chinese market. He is instrumental in utilizing Caidya’s distinct global presence – especially in China – to establish effective multi regional clinical trial (MRCT) processes that set Caidya apart. Jack works closely with the Caidya Executive Leadership Team to ensure that all initiatives in China are aligned with the company’s global mission.
Jack brings a wealth of expertise to his role with over 20 years of management experience in global biopharmaceutical companies and CROs, including GlaxoSmithKline, AstraZeneca, Pfizer, and Parexel.
He holds a Doctorate in Biostatistics and a Master’s degree in Pharmacology from Fudan University and gets his Bachelor’s degree in Medical Informatics from Jilin University.
Access the right people when and where you need them with personalized clinical services tailored to you and your trial.
Explore our news and updates as we deliver a superior customer experience.
News
03/13/2025
News
01/28/2025
News
01/13/2025